NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹345 Cr | ₹189 Cr | ₹122 Cr | ₹147 Cr | ₹180 Cr |
What is the latest Total Non-Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹345 Cr |
| Mar2025 | ₹189 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹147 Cr |
| Mar2022 | ₹180 Cr |
How is Total Non-Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹345 Cr | 82.41 | |
| Mar2025 | ₹189 Cr | 55.02 | |
| Mar2024 | ₹122 Cr | -16.73 | |
| Mar2023 | ₹147 Cr | -18.42 | |
| Mar2022 | ₹180 Cr | - | |
Compare Total Non-Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹28,983.4 Cr | -1.3% | 5.3% | 71.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.3% |
5.3% |
71.1% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses